Screening and discovering drugs for the treatment of infectious diseases is a crucial task, forming the core of combating infectious diseases and ensuring public health safety. Infectious diseases such as influenza, AIDS, and novel coronaviruses have the characteristic of rapid transmission, posing a significant threat to public health. Effective therapeutic drugs are not only hoped to cure or control the disease, but more importantly, they can slow down the spread of the virus and significantly reduce the risk of widespread outbreaks. Furthermore, in the face of the growing drug resistance of pathogens, the development of new drugs is particularly critical. Creative Biolabs is committed to supporting our clients in continuous screening and R&D in this field, accelerating the R&D process of infectious disease treatment drugs, and contributing to the global health cause.
Learn more: viral diseases